Breaking the 60/40 Mold: Life Settlements and the Future of Portfolio Diversification

The Death of 60/40 and Rise of the Alternatives

The traditional 60/40 stock-bond portfolio has long been a staple of institutional investing. But even the largest asset managers are now questioning its efficacy. BlackRock’s Larry Fink recently proclaimed that the classic 60/40 mix is “no longer in favor”, suggesting it’s time to tear up the old playbook in favor of something more resilient (1). In his 2025 annual letter, Fink hinted that the portfolio of the future may include ~20% in alternatives (2). This forward-thinking (some might say rebellious) stance comes on the heels of 2022 – a year when 60/40 portfolios suffered their worst performance since 2008 (3). With both stocks and bonds falling in tandem, investors learned the hard way that “diversification” needs to mean more than just two asset classes. 

So what replaces the old 60/40? Enter alternative investments. Private equity, real estate, and hedge funds have all been touted as options, but there’s a lesser-known alternative now stepping into the spotlight: life settlements. As I discussed in my previous article “The Network Effect of Life Settlements” this niche asset class has been quietly building momentum, creating a network effect of value for investors and policyholders alike (4). In many ways, life settlements are becoming the connective tissue of modern portfolios – linking uncorrelated yield to the parts of the market starved for stability (a theme I explored in “Life Settlements as Connective Tissue”). Now, with even Wall Street titans proclaiming the death of 60/40, life settlements are emerging as a compelling candidate to fill that void. 

What Are Life Settlements? A Primer

For those unfamiliar, life settlements involve the purchase of an existing life insurance policy from its original owner, at a discount to its face value. The investor pays the remaining premiums and eventually collects the death benefit. In essence, this unlocks value from an otherwise illiquid asset (a life policy) and turns it into an investment stream decoupled from traditional market drivers (5). Unlike equities (tied to corporate earnings and economic cycles) or bonds (sensitive to interest rates), the performance of life settlements hinges on a completely unrelated factor – human longevity (6).

Why is this so powerful? Because it means life settlements have virtually no correlation to stock or bond markets. Market crash, credit crisis, Fed rate hike – none of these directly affect the timing of life insurance payouts. This uncorrelated nature provides true diversification: adding life settlements can reduce overall portfolio risk by introducing an asset whose outcomes don’t move in tandem with market swings (7). In fact, over 80% of investors in a recent study cited diversification as the top advantage of life settlements (8).

Equally important are the return characteristics. Industry data show net expected IRRs in the high-single to low-double digits (roughly 8%–11% net annually) for well-diversified life settlement portfolios (9). These yields outpace typical fixed-income instruments – a critical edge in an era when core bond yields have been low or volatile (10). Some even compare life settlements to high-yield bonds, but with better risk-adjusted returns (no credit default risk) and a payoff ultimately backed by investment-grade insurers (11). In other words, life settlements can offer the upside of alternative investments with downside protection akin to an insurance obligation (12). Little wonder they’re often described as a “high-yield, low-beta” addition to portfolios (13).

Key takeaway: Life settlements are an established asset class (over $10 billion of policies traded annually) that provides uncorrelated, insurance-backed cash flows. They generate yield from longevity outcomes, not corporate profits. This makes them a powerful tool for diversification and stable returns – exactly what a modern portfolio needs as we venture beyond the 60/40 paradigm.

Outperforming 60/40: Data-Driven Evidence

It’s one thing to claim uncorrelated, high returns – but how do life settlements actually impact a portfolio’s performance versus the traditional 60/40 mix? To answer that, let’s look at the numbers. Recent analysis by EverOak Innovations (a life settlements specialist) compared a plain 60/40 portfolio to portfolios that replace a portion of the bonds with life settlements. The results are striking. 

Cumulative return comparison and risk metrics for a traditional 60/40 portfolio vs. portfolios including life settlements. Re-allocating even 5–20% of a 60/40 portfolio into life settlements materially boosts returns and lowers volatility. In this model, a 60/20/20 mix (60% equities, 20% bonds, 20% life settlements) delivered ~9.8% annualized return with 10.8% volatility, versus ~7.8% and 11.2% for the classic 60/40. Over six years, that translates to ~14% cumulative excess return above the traditional portfolio.

In plain English, a modest life settlement allocation significantly improved the 60/40 portfolio’s risk-reward profile. By substituting 20% of bonds with life settlements, annual returns increased from about 7.8% to 9.8%, while volatility actually decreased (from 11.2% to 10.8%). Even a 5% allocation to life settlements bumped returns to 8.3% with slightly lower volatility. This data makes a strong case that life settlements can enhance cumulative yield without adding risk – in fact, they reduced overall portfolio standard deviation in the analysis. The cumulative performance graph tells the story: the lines representing portfolios with life settlements steadily pull away from the flat 60/40 line, achieving higher total growth with milder swings.

Beyond returns and volatility, consider drawdowns and Sharpe ratios. In 2022, a 60/40 portfolio saw a drawdown on the order of -16% (14). A life settlements portfolio, by contrast, isn’t exposed to market sell-offs – it likely would have held steady or still produced positive gains during that period. This resilience yields superior risk-adjusted returns. Imagine one asset that returns ~9-10% with hardly any volatility, vs. another that returns ~7% with frequent 10%+ swings – the former’s Sharpe ratio will be dramatically higher. That’s exactly the case here. Studies of life settlement funds show annual volatility as low as ~2–3%, compared to ~6–8% for bonds and ~15% for equities (15). One research paper found open-end life settlement funds had ~2.3% annual standard deviation, roughly half the volatility of U.S. Treasuries (3.8%) and a small fraction of equity volatility (~15%) (16). In practical terms, a well-managed life settlements strategy can deliver equity-like returns with bond-like (or better-than-bond) volatility – a rare combo of high yield and low correlation with intrinsic downside protection (17).

Let’s summarize this modern portfolio math in a quick table: 

Table: Comparing a traditional 60/40 portfolio to life settlements. Life settlements historically offer similar returns with a fraction of the volatility, yielding far higher risk-adjusted performance (Sharpe) and minimal drawdowns, thanks to near-zero correlation with equity markets. 

The data makes it clear: including life settlements can materially improve a portfolio’s risk/reward. This isn’t about completely replacing stocks and bonds, but enhancing the mix – essentially upgrading the 60/40. As one might say, the 60/40 portfolio isn’t dead, it’s just evolving – with life settlements providing the boost that traditional assets can’t in today’s environment.

AI and Technology: Underwriting in Minutes, Not Months

One reason life settlements have gained traction now (beyond their performance) is the revolution in technology and AI within this domain. Historically, valuing a life insurance policy (for a life settlement) was a slow, labor-intensive process. It involved obtaining medical records, actuarial analysis of life expectancy, and complex legal due diligence – often taking months to underwrite a single policy. This lengthy process added cost, opacity, and risk (e.g. risk of mispricing or changes in the insured’s health during the wait).

Fast forward to today: Artificial intelligence and data analytics can transform life settlements. Advanced algorithms can analyze medical records and mortality data in seconds, while machine learning models continuously improve life expectancy estimates. A Manager, for example, can leverage a proprietary AI-driven underwriting platform that can evaluate a policy’s risk and value in minutes rather than months. By digitizing medical files and using predictive modeling, they could dramatically speed up pricing and increase accuracy. What does this mean for investors? A faster, more efficient market with greater transparency and lower operational risk. When you can instantly cross-check life expectancies and pricing against large datasets of mortality experience, you reduce the chances of overpaying for a policy or encountering unpleasant surprises. Technology can cut the valuation process from “months to minutes”, boosting efficiency, transparency, and accuracy in an unprecedented way.

This tech-driven approach also enables better portfolio construction. AI models can optimize a pool of life policies to achieve target returns and risk characteristics, much like Modern Portfolio Theory does for stocks/bonds. For instance, algorithms can ensure diversification across age, health conditions, and insurance carriers, or simulate thousands of scenarios to stress-test outcomes. The result is an asset class that was once considered esoteric and opaque now becoming accessible, data-driven, and institution-friendly. In short, FinTech and InsurTech advances can turn life settlements into a 21st-century investment product – one that can keep up with the real-time demands of global investors. 

Designing a Future-Proof Portfolio (Targeting Double-Digit IRRs)

What does an optimized life settlements strategy look like in practice? While I won’t name specific funds, the characteristics of leading strategies in this space are worth noting – especially as they align perfectly with the needs of a post-60/40 world:

• Proprietary Modeling & Analytics: The top manager should use in-house models (often AI-enhanced) to project mortality and cash flows more accurately than traditional actuarial tables. This modeling edge means more precise pricing of policies and better risk management. It’s a bit like having a smarter radar – you can navigate the portfolio through longevity risk with more confidence.

• Diversified Structuring: Successful life settlement portfolios hold hundreds (even thousands) of policies, diversified across different insurance carriers, policy sizes, and demographic profiles. This law of large numbers smooths out the variance in outcomes – one policy maturing a bit late or early won’t make or break the fund. Diversification also extends to structuring: some strategies use tranches or pooling vehicles to tailor risk/return for different investor classes. The end goal is stable, predictable cash flows from a large pool of uncorrelated assets.

• Targeted Double-Digit IRRs: It’s common to see target net IRRs in the low teens (10%+). These targets are ambitious yet grounded in historical performance of the asset class (18). Achieving them requires active management: continually sourcing high-quality policies, negotiating good purchase prices, and minimizing expenses (premiums, servicing costs). With experienced teams – often comprised of insurance experts, medical underwriters, and finance professionals – many funds have indeed delivered or exceeded these double-digit returns in past vintage years. Importantly, these returns tend to come with low volatility, as discussed, meaning the quality of return (in Sharpe terms) is exceptionally high.

In essence, an allocation to life settlements in 2025 doesn’t mean taking a blind leap into an unknown asset. It means partnering with an innovative asset manager running a data-driven, well-diversified strategy that has been refined over years. This strategy acts as a powerful complement to stocks and bonds. It’s not about taking unnecessary risk; it’s about shifting the efficient frontier outward – getting better returns for the same or lower risk. The goal is to generate “uncorrelated and superior risk-adjusted returns” for the portfolio. That is the holy grail for institutional investors dissatisfied with the status quo.

Conclusion: A New Paradigm

Larry Fink’s pronouncement that the 60/40 portfolio is dead may sound bold, but it resonates with investors who have watched that old formula falter in recent years. The search is on for the new formula – one that can thrive in a world of low yields, high volatility, and unpredictable correlations. Life settlements are proving to be a strong candidate for that formula, offering a rare mix of high yields, low correlation, and reliability backed by contractual insurance payouts (19). They exemplify the kind of outside-the-box thinking that can rejuvenate portfolio design – the very essence of breaking the 60/40 mold.

For institutional and accredited investors across the US, Europe, and Asia, the message is clear: consider making life settlements part of your diversification toolkit. Whether as an enhancement to the bond sleeve of your portfolio or as a standalone alternative allocation, life settlements can play the role of return booster, volatility damper, and crisis alpha generator all in one. They align with the modern mandate to seek true diversification and better risk-adjusted returns in every environment. 

Over the past weeks, I’ve written about the evolving landscape of life settlements – from their network effects to their integration in portfolios – and I firmly believe this is just the beginning of a larger trend. If you’re curious how life settlements might fit into your own portfolio strategy, or you want to discuss the practical aspects of allocation, don’t hesitate to reach out.